Thus, neurons are metabolically inflexible cells unable to adapt to the sustained active glycolysis that is linked with neurological and metabolic syndromes, in which neuron-specific inhibition of PFKFB3 may be considered as a therapeutic opportunity. This evidence concerns the gene PFKFB3 and metabolic syndrome.